Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.

Teachey DT, Greiner R, Seif A, Attiyeh E, Bleesing J, Choi J, Manno C, Rappaport E, Schwabe D, Sheen C, Sullivan KE, Zhuang H, Wechsler DS, Grupp SA.

Br J Haematol. 2009 Apr;145(1):101-6. doi: 10.1111/j.1365-2141.2009.07595.x. Epub 2009 Feb 4.

2.

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT.

Blood. 2016 Jan 7;127(1):17-28. doi: 10.1182/blood-2015-07-657981. Epub 2015 Oct 26.

3.

Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.

Cayrol J, Garrido Colino C.

J Pediatr Hematol Oncol. 2017 May;39(4):e187-e190. doi: 10.1097/MPH.0000000000000785.

PMID:
28234735
4.

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).

Rao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, Dale JK, Gill F, Hartman KR, Stork LC, Gnarra DJ, Krishnamurti L, Newburger PE, Puck J, Fleisher T.

Pediatr Blood Cancer. 2009 Jul;52(7):847-52. doi: 10.1002/pbc.21965.

5.

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.

Rao VK, Dugan F, Dale JK, Davis J, Tretler J, Hurley JK, Fleisher T, Puck J, Straus SE.

Br J Haematol. 2005 May;129(4):534-8.

PMID:
15877736
6.

Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome.

Janić MD, Brasanac CD, Janković JS, Dokmanović BL, Krstovski RN, Kraguljac Kurtović JN.

Pediatr Blood Cancer. 2009 Dec;53(6):1117-9. doi: 10.1002/pbc.22151.

PMID:
19588524
7.

[Primary immunodeficiencies presenting with autoimmune cytopenias in adults].

Sève P, Broussolle C, Pavic M.

Rev Med Interne. 2013 Mar;34(3):148-53. doi: 10.1016/j.revmed.2012.05.007. Epub 2012 Jun 15. Review. French.

PMID:
22703729
8.

Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.

George LA, Teachey DT.

Paediatr Drugs. 2016 Aug;18(4):261-72. doi: 10.1007/s40272-016-0175-3. Review.

PMID:
27139496
9.

[Rapamycin treatment of recurrent autoimmune hemolytic anemia in 28 cases].

Liu QC, Li JY, Ma YH.

Zhonghua Xue Ye Xue Za Zhi. 2012 Mar;33(3):241-2. Chinese. No abstract available.

PMID:
22781619
10.

Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus.

Cooper SL, Arceci RJ, Gamper CJ, Teachey DT, Schafer ES.

Pediatr Blood Cancer. 2016 Feb;63(2):358-60. doi: 10.1002/pbc.25770. Epub 2015 Oct 9.

PMID:
26452062
11.

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).

Teachey DT, Obzut DA, Axsom K, Choi JK, Goldsmith KC, Hall J, Hulitt J, Manno CS, Maris JM, Rhodin N, Sullivan KE, Brown VI, Grupp SA.

Blood. 2006 Sep 15;108(6):1965-71. Epub 2006 Jun 6.

12.

Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.

Svahn J, Fioredda F, Calvillo M, Molinari AC, Micalizzi C, Banov L, Schmidt M, Caprino D, Marinelli D, Gallisai D, Dufour C.

Br J Haematol. 2009 Apr;145(1):96-100. doi: 10.1111/j.1365-2141.2009.07594.x. Epub 2009 Feb 4.

PMID:
19208098
13.

Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience.

Jasinski S, Weinblatt ME, Glasser CL.

J Pediatr Hematol Oncol. 2017 Aug;39(6):420-424. doi: 10.1097/MPH.0000000000000818.

PMID:
28267088
14.

Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children.

Miano M, Calvillo M, Palmisani E, Fioredda F, Micalizzi C, Svahn J, Banov L, Russo G, Lanza T, Dufour C.

Br J Haematol. 2014 Nov;167(4):571-4. doi: 10.1111/bjh.13010. Epub 2014 Jun 30. No abstract available.

PMID:
24975111
15.

Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.

Acquazzino MA, Fischer RT, Langnas A, Coulter DW.

Pediatr Transplant. 2013 Aug;17(5):466-71. doi: 10.1111/petr.12101. Epub 2013 Jun 3.

PMID:
23730873
16.

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.

Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K, Nash RA, Papayannopoulou T, Storb R, Sullivan KM, Witherspoon R, Deeg HJ.

Transplantation. 2001 Dec 27;72(12):1924-9.

PMID:
11773890
17.

Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.

Miano M, Scalzone M, Perri K, Palmisani E, Caviglia I, Micalizzi C, Svahn J, Calvillo M, Banov L, Terranova P, Lanza T, Dufour C, Fioredda F.

Br J Haematol. 2015 Jun 8. doi: 10.1111/bjh.13533. [Epub ahead of print]

PMID:
26058843
18.

New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Teachey DT.

Curr Opin Pediatr. 2012 Feb;24(1):1-8. doi: 10.1097/MOP.0b013e32834ea739. Review.

19.

Primary immunodeficiencies (PIDs) presenting with cytopenias.

Notarangelo LD.

Hematology Am Soc Hematol Educ Program. 2009:139-43. doi: 10.1182/asheducation-2009.1.139. Review.

PMID:
20008192
20.

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.

Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM.

Br J Haematol. 2007 Jul;138(1):94-6. Epub 2007 May 11.

PMID:
17498197

Supplemental Content

Support Center